Hepatic encephalopathy is a brain dysfunction caused by liver disease or portosystemic shunting. It manifests as a wide spectrum of neurological or psychiatric abnormalities ranging from subtle alterations to coma. The main neurotoxin involved is ammonia, which is normally cleared by the liver. In liver disease, ammonia builds up in the blood and brain, where it interferes with neurotransmission. Symptoms include impaired cognition, personality changes, asterixis, and eventually coma. Hepatic encephalopathy is classified based on the underlying liver disease, time course, presence of precipitating factors, and severity of symptoms.
What is Hepatic Encephalopathy.
What is the Grading of Hepatic Encephalopathy.
How to Diagnose Hepatic Encephalopathy .
How to Treat Hepatic Encephalopathy.
This is a lecture note for 5th semester MBBS students. Lecture notes on hepatology, liver disease, alcoholic liver disease, alcohol-related liver disease, portal hypertension, and hepatic encephalopathy. Introduction to hepatic encephalopathy, causes, differentials, approach, and management of hepatic encephalopathy .
What is Hepatic Encephalopathy.
What is the Grading of Hepatic Encephalopathy.
How to Diagnose Hepatic Encephalopathy .
How to Treat Hepatic Encephalopathy.
This is a lecture note for 5th semester MBBS students. Lecture notes on hepatology, liver disease, alcoholic liver disease, alcohol-related liver disease, portal hypertension, and hepatic encephalopathy. Introduction to hepatic encephalopathy, causes, differentials, approach, and management of hepatic encephalopathy .
A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
Acute kidney injury (AKI) is a potentially life-threatening
syndrome that occurs primarily in hospitalized patients
and frequently complicates the course of critically ill
patient.
Acute Kidney Injury is is (abrupt) reduction in kidney functions as evidence by changed in laboratory values; serum creatinine, blood urea nitrogen(BUN)and urine output
A simple description of a less understood topic in Intensive Care Medicine. Aim to make understanding and management easy for the residents and prevention steps for all ICU workers.
Acute kidney injury (AKI) is a potentially life-threatening
syndrome that occurs primarily in hospitalized patients
and frequently complicates the course of critically ill
patient.
Acute Kidney Injury is is (abrupt) reduction in kidney functions as evidence by changed in laboratory values; serum creatinine, blood urea nitrogen(BUN)and urine output
Hepatic encephalopathy is a brain dysfunction caused by liver insufficiency, and/or portosystemic shunt; it manifests as a wide spectrum of neurological or psychiatric abnormalities ranging from subclinical alterations to coma.
Its a common disorder in liver cirrhosis
dr Mohammed Hussien ( assistant Lecturer of Gastroenterologist and Hepatology at Kaferelsheik University Egypy) illusterating one of Major complication of Cirrhosis --H.E
Effective treatment for epilepsy in Mindheal Homeopathy clinic ,Chembur, Mumb...Shewta shetty
"epilepsy-it is a brain disorder in which the person has repeated convulsions over a period of time. Epilepsy occurs when permanent changes in the brain tissue cause it to be excitable or jumpy. The brain sends out abnormal signals. Mindheal homeopathy is more effective in the treatment of epilepsy then conventional medicine."/>
Effective treatment for epilepsy in Mindheal Homeopathy clinic ,Chembur, Mumb...Shewta shetty
"epilepsy-it is a brain disorder in which the person has repeated convulsions over a period of time. Epilepsy occurs when permanent changes in the brain tissue cause it to be excitable or jumpy. The brain sends out abnormal signals. Mindheal homeopathy is more effective in the treatment of epilepsy then conventional medicine."/>
Hepatic encephalopathy (HE) is defined as a neuropsychiatric syndrome in patients with liver dysfunction, characterized by personality changes, intellectual impairment and decreased level of consciousness (after exclusion of brain disease).
•Its mainly due to liver failure or portosystemic shunting of blood.
•Portosystemic shunting is divertion of portal blood into the systemic circulation through portosystemic collateral vessels (liver is bypassed).
•Shunting can either be surgical / spontenious.
organo phosphorus poisning(op) is a common type of poisning due to consumption of highly toxic organophosphorus usually available in agriculture pesticides and herbicides. it may lead to high toxic effects when consumed for the suicide purpose.
Rivaroxaban with or without aspirin in patients with stable peripheral or car...Bhargav Kiran
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
2. History
• Hippocrates (460–371 B.C.) described the association between jaundice and acute
behavioral disturbances.
• GB. Morgagni (1682–1771) reported the history of a noble from Venice who was an alcohol
misuser in the past. This man developed ascites and some episodes of agitation, and then he
developed prolonged episodes of somnolence and delirium and finally died. His autopsy
revealed the existence of liver cirrhosis (the Morgagni-Laennec cirrhosis).
• Hann et al, 1893; who showed that dogs undergoing experimental portal- caval shunt
develop behavioral changes within 10–40 days after surgery [meat intoxication syndrome].
History
3. • van Coulert et al 1932; reported the capacity of ammonia to induce coma or
stupor in patients with cirrhosis.
• S. Sherlock et al., 1954; defined hepatic encephalopathy and coined it as
portal-systemic encephalopathy.
• Fazekas, et al 1957; coined new term ‘hepatic encephalopathy’ (HE).
• Rikkers et al 1978; first identification of latent HE.
• H. Schomerus, W. Hamster, 1998: coined MHE.
4. Definition :
Hepatic encephalopathy is a brain dysfunction
caused by liver insufficiency and/or Porto-systemic
shunting
It manifests as a widespectrum of neurological or
psychiatric abnormalities ranging from subclinical
alterations to coma.
5. Incidence : Epidemiology
It develops in 50-70% of patients with Cirrhosis
Its occurrence is a poor prognostic indicator
with a projected 1 and 3 year survival rates of 42% and 23 % respectively without
liver transplantation
The prevalence of OHE at the time of diagnosis of cirrhosis is 10%–14% in general.
In decompensated cirrhosis is 16–21%. After TIPS: 10-50%.
The risk for the first bout of OHE is 5%–25% within 5 years after cirrhosis diagnosis.
Recurrence:
40% within 1st year after index OHE.
Subjects with recurrent OHE have a 40% cumulative risk of another recurrence
within 6 months, despite lactulose treatment.
6. Pathophysiology
A number of factors have been implicated like
Production of neurotoxins
Altered permeability of blood brain barrier
Abnormal neurotransmission
The best described neurotoxin involved is ammonia
• Once produced it will enter portal circulation and gets metabolized and cleared by hepatocytes
• In cirrhosis and portal HTN reduced hepatocyte functioning contribute to increased circulating
ammonia levels.
8. Astrocytes are the only cells in the brain that can metabolize
ammonia .
𝑁𝐻3 𝑁𝐻3
α keto-glutaric acid → → → glutamic acid → → → glutamine
synapsis.
Glutamine accumulation astrocyte swelling brain edema.
In FHF [type AHE]:
Marked elevation of the ammonia glutamate excitatory changes agitation,
confusion, seizures and coma.
Glutamine is osmolyte so that it causes cerebral edema and increased intracranial tension.
Ammonia And The Brain
9. Increased permeability of blood brain barrier increases the uptake and extraction of
ammonia by cerebellum and basal ganglia
Acute hyperammonemia appears to have a direct effect on brain edema , astrocyte
swelling and transport of neutrally active compunds such as myoinositol there by
causing HE.
However Serum Ammonia levels are neither specific nor a sensitive test .
10. CLINICAL PRESENTATION
Hepatic encephalopathy produces a wide spectrum of nonspecific neurological and psychiatric manifestations.
In its lowest expression HE alters only psychometric tests oriented toward attention, working memory,
psychomotor speed, and visuospatial ability
As HE progresses, personality changes, such as apathy, irritability, and disinhibition, may be reported by the
patient’s relatives, and obvious alterations in consciousness and motor function occur.
Disturbances of the sleep wake cycle with excessive daytime sleepiness are frequent.
Patients may develop progressive disorientation to time and space, inappropriate behavior, and acute
confusional state with agitation or somnolence, stupor, and, finally, coma.
The recent ISHEN (International Society for Hepatic Encephalopathy and Nitrogen Metabolism) consensus
uses the onset of disorientation or asterixis as the onset of OHE
11. Asterixis / flapping tremor”
It is often present in the early to middle stages of HE that precede stupor or coma
It is actuality, not a tremor, but a negative myoclonus consisting of loss of postural tone.
It is easily elicited by actions that require postural tone, such as hyperextension of the wrists with
separated fingers or the rhythmic squeezing of the examiner’s fingers.
12. • Is a flapping tremor.
• Cause:
• Imbalance between the agonist and
antagonist muscle due to disturbed
diencephalic motor centers
• Detection areas:
• tongue, and the upper and lower
extremities.
• Not specific to the liver:
• Carbon dioxide intoxication, uremia, organ
failure and stroke of basal ganglia.
• Not seen in advanced cases and coma.
13. Symptom Cause Comments
Altered mental status, memory
loss, disorientation, personality
changes, memory impairment,
shortened attention span, slurred
speech, confusion, coma
Cerebral edema (varying degrees)with
astrocyte swelling
GABA toxiceffects
Systemic inflammation
Alterations in the cerebral blood flux and in
the oxidative metabolism
Altered communication between the astrocyte and the
neuron
Trojan horse theory: oxidative stress caused by
mitochondrial ammonia accumulation (glutamate
transport)
Cerebral edema (varying degrees)with
astrocyte swelling
GABA toxiceffects
Alterations in the cerebral blood flux and in
the oxidative metabolism
Rarely occurs
Transient focal neurologic
deficits or seizures
Asterixis (flapping tremors)
Abnormal function of diencephalic motor
centers that regulate the tone of agonist
and antagonist muscles, normally
involved in maintaining posture
Adams and Foley first described asterixis in 1949 in
patients with severe liver failure and encephalopathy
Present in early to middle stages of HE
Not pathognomonic; it occurs with renal failure,
hypercapnia, and stroke affecting basal ganglia
Asterixis does not occur in advanced HE
Never seen in coma
Testing for asterixis 1
3
14. Symptom Cause Comments
Hyperventilation Associated with acidotic pH
Compensatory mechanism that
decreases the entrance of ammonia
into the brain
It has also been related to increased levels of estrogens and
progesterone
Hepatic dementia Pathogenetic mechanism is obscure
Associated neuronal loss
In chronic HE
Fluctuating symptoms with periods of improvement and a subcortical
pattern
The initial manifestations are attention deficits, visuopractic
abnormalities, dysarthria, and apraxia
Seen rarely; is reversible after LT/TIPS
Hepatic parkinsonism Pathogenetic mechanism is obscure
Associated demyelination along the
pyramidal tract
In chronic HE
Resembles Parkinson disease, except for a symmetric presentation and
lack of significant tremor
Hepatic myelopathy Pathogenetic mechanism is obscure In chronic HE
Usually motor abnormalities exceed mental deterioration
Is characterized by a progressive spastic paraparesis accompanied
by hyperreflexia and extensor plantar responses
Only a few patients have sensory symptoms or incontinence
Does not respond to standard therapy
36
15. Symptom
1
5
Cause Comments
Hyperreflexia, hypertonia, or
extensor plantar responses
Pyramidal involvement Never seen in coma
Parkinsonian symptoms:
bradykinesia, tremors
Deposition of manganese in the basal ganglia
(globus pallidus and substantia nigra)
Manganese induces changes
in astrocytes of the basal ganglia that
promote the formation of Alzheimer
type II astrocytes
Manganese acts as a neurotoxin to
stimulate translocator proteins on
astrocytes
Tics or chorea are rare
Severe Parkinson seen only in chronic
HE
Sleep latency, sleep
fragmentation, inversion of
sleep-wake pattern
Impaired hydroxylation and sulfation to 6- —
sulfatoxymelatonin in the liver
Ammonia levels
Fetor hepaticus
Attributed to dimethyl sulfide, a volatile sulfur
compound that can be identified in the breath
and serum of patients with cirrhosis
Found in cirrhotics with or without HE
16. CLASSIFICATION
Hepatic encephalopathy should be classified according to all of the following four factors.
1. According to the underlying disease, HE is subdivided into
• Type A resulting from ALF
• Type B resulting predominantly from porto-systemic Bypass or shunting
• Type C resulting from cirrhosis
2.According to its time course, HE is subdivided into
• Episodic HE
• Recurrent HE denotes bouts of HE that occur with a time interval of 6 months or less.
• Persistent HE denotes a pattern of behavioral alterations that are always present and interspersed
withrelapses of overt HE.
18. 3.According to the existence of precipitating factors, HE is subdivided into
• Nonprecipitated
• Precipitated
The precipitating factors should be specified.
Precipitating factors can be identified in nearly all bouts of episodic HE type C and should be
actively sought and treated when found
19. Clinical diagnostic criteria
1
9
West-Haven criteria for HE
Stage Consciousness Intellect and behaviour Neurological findings
0 Normal Normal
Normal examination; if impaired
psychomotor testing, then MHE
1 Mild lack of awareness
Shortened attention span;
impaired addition or subtraction
Mild asterixis or tremor
2 Lethargic
Disoriented; inappropriate
behaviour
Obvious asterixis; slurred speech
3 Somnolent but arousable
Gross disorientation; bizarre
behaviour
Muscular rigidity and clonus;
Hyperreflexia
4 Coma Coma Decerebrate posturing
26. HE DESCRIPTION with CLINICAL EXAMPLE
The HE patient should be characterized by one component from each of the four columns.
Example of a recommended description of a patient with HE: “The patient has HE, Type C,
Grade 3, Recurrent, Precipitated (by urinary tract infection).”
28. Diagnosis : Tests
Portosystemic encephalopathy (PSE) syndrome test : This test battery
consists of five paper-pencil tests that evaluate cognitive and psychomotor
processing speed and visuomotor coordination.
The tests are relatively easy to administer and have good external validity.
The Continuous Reaction Time (CRT) test: The CRT test relies on
repeated registration of the motor reaction time (pressing a button) to
auditory stimuli (through headphones).
The most important test result is the CRT index, which measures the stability of the
reaction times.
29. Paper-and-pencil Psychometric Tests
Psychometric Hepatic Encephalopathy Score (PHES):
Validated for MHE diagnosis in Germany, Italy and Spain not USA.
Number connection test:
part A[NCT-A]
part B [NCT-B]
Digital symbol test [DST]
Serial dotting test [SDT]
Block design test [BDT]
Line “trail” tracing test [LTT]
96%sensitivity and 100% specificity. If <-4 is diagnostic, <-6 is of poor
prognosis.
If not available then abnormalities in 2 of the tests (at least 2 standard deviations
from age-and education-matched controls)
Easy but time consuming, difficult to interpret, patient must be literate with
fine motor activities [pencil and paper].
51
31. Repeated battery for the assessment of
neuropsychological status (RBANS)
• RBANS has been used for the evaluation of Alzheimer’s
disease, schizophrenia, traumatic brain injury in 20-25m.
• Was tested in a selected population of patients with
cirrhosis awaiting liver transplantation.
• It has not been specifically validated in HE.
• The test has 2 domains, cortical and subcortical.
• HE patients predominantly perform worse in the sub-
cortical component.
• The applicability of RBANS in practice is limited
because it must be administered and scored by a
psychologist. 3
1
32. Neuropsychological Tests
3
2
• They are offered under the supervision of a neurologist and require
specialized equipment, personnel and time.
• EEG and Visual evoked potentials:
• have not been shown to provide diagnostic information critical for the
diagnosis of CHE
• Brainstem auditory evoked potentials
• Critical flicker frequency
33. Critical Flicker Frequency (CFF)
• Flicker light is going on and off repeating.
• No need for a psychologist, short period of time & minimal
costs.
• Principle:
• In HE the retinal cells like astrocytes undergoes edema “hepatic
retinopathy”
• Light from 60Hz and gradually decreasing till flickering.
• The subject has to press a button as soon as the impression of fused
light switches to flickering light.
• CFF threshold of 38–39 Hz
• After patient training, done 8 times and the mean value is calculated as
CFF.
• Drawbacks:
• ot validated in USA.
• It requires intact binocular vision and absence of red-green blindness.
• Fogging of glasses.Age,medications.
• Moderated sensitivity and specificity so should be used for follow up.
Pulsating
light emitting
diode
3
3
The HEPAtonorm™ Analyzer consists of a) hand
held control unit b) headset c) patient stop button
34. The Stroop SmartphoneApplication
• It is developed by Bajaj et al., 2013.
• It is a short and recently validated test, simple, easy, no need for psychologist.
• EncephalApp—Stroop Test is available as a free download on iTunes.
• It measures psychomotor speed and cognitive flexibility and have been
validated for the diagnosis of CHE.
• It consists of identifying the color of symbols presented, delineating the correct color of a
color word that is a different color than the word itself (e.g., red in a green-colored font), and
reaction times.
• It assesses time to correctly identify a series of symbols with different colors (off-time) and
printed words with different colors (on-time).
• A cut-off time of more than 190 seconds identified CHE with excellent accuracy.
• OHE patients do worse than those without OHE.
• It correlated with accidents and illegal turns in driving simulation tests. 3
4
36. 67
Diagnostic test Advantages Disadvantages
Serum levels of ammonia
Positively correlated with the severity ofHE Does not change approach to diagnose and manageHE
Can be challenging to take appropriate blood samples in theclinic
Clinical scales for OHE
West Haven criteria
Well-established classification criteria (in use for ≈30years)
Used in multiple studies ofOHE
Interobservervariation influencestest results (especially for low grades of HE)
HE Scoring Algorithm
Minimal variability in results between different testsites
Characterizes low grades ofHE
Time consuming (which may be a limiting factor in the outpatientsetting)
Neuropsychometric tests ('paper and pencil' tests) for MHE
Psychometric HE score
Specifically designed to diagnose subtle cognitive changes in patients withMHE
Endorsed as the 'gold standard' by the Working Party at the 1998 World Congress of
Gastroenterology, Vienna,Austria
Poor test of memory
Difficult to interpret andscore
Excessive reliance on measuring fine motorskills
Unpopular in USA (lack of US-specific normative data andavailability)
Repeatable Battery for the
Assessment of Neurological
Status
Tests can be completed rapidly (within 25min) Difficult to interpret andscore
Excessive reliance on measuring fine motorskills
Computerized psychometric tests for MHE
Inhibitory control test
Detects MHE with highsensitivity
Validated against existing psychometrictests
Studies using this test have mostly been conducted in a single institution located ineither
Wisconsin or Virginia,USA
CDR system
Correlates well with neuropsychometrictests Time consuming, which could be a limitingfactor
Trial run needed before formaltesting
Neurophysiologic tests
Critical flicker frequency
High sensitivity and specifity
Correlates well with neuropsychometric tests Widely
used in clinicaltrials
Lack of widespread availability in the USA to permit use in ambulatorypatients
Electroencephalography HE associated with slow frequency of electricalactivity Variable sensitivity for the diagnosis of HE(43–100%)
Brain imaging
MRI
Multiple techniquesavailable
Identifies several brain abnormalities associated with HE (e.g. levels ofglutamate)
Can be expensive (especially the newer techniques that show low grades of cerebraledema)
CT
Useful for excluding other causes ofencephalopathy
Identifies conditions that worsen HE (subdural hematoma or a cerebrovascular event)
Poor detection of low grades of cerebral edema in most patients withHE
Risk associated with radiationexposure
Abbreviations: CDR, Cognitive Drug Research computerized assessment; HE, hepatic encephalopathy; MHE, minimal hepatic encephalopathy;OHE, overt hepatic encephalopathy.
37. LABORATORY TESTING
High blood-ammonia levels alone do not add any diagnostic, staging, or prognostic
value in HE patients with CLD.
Brain Imaging :
Magnetic Resonance Spectroscopy (MRS)
MR T1 mapping with partial inversion recovery (TAPIR)
They are used to measure clinical parameters quantitatively.
38. 66
MRI technique Imaging abnormality Clinical correlate
T1-weighted imaging Bilateral, symmetrical, high-
intensity signal in the basal ganglia
(globus pallidus and substantia
nigra)
Attributed to preferential deposition of manganese in the
basal ganglia
Found in patients with cirrhosis who have substantial
portosystemic shunts
No quantitative relation to severity of HE
Reverses after liver transplantation
Proton spectroscopy
(1H MRS)
Increase in glutamate and
glutamine signals
Decrease in myoinositol and
choline signals
Homeostatic compensatory metabolic changes occur in
the astrocytes of patients with chronic liver failure that
prevent massive cerebral edema
Changes seen on MRS imaging usually correlate with the
severity of HE
Changes resolve after liver transplantation
Magnetic transfer ratio Mild, diffuse reduction in magnetic
transfer ratio in the white matter
Reflects mild cerebral edema
Reverses after liver transplantation
T2-weighted FLAIR
sequence and diffusion
weighted imaging
Diffuse increase in white matter
signal intensity in the cerebral
hemispheres and the corticospinal
tract
Observed changes because of cerebral edema
Could explain neurologic abnormalities in patients with
cirrhosis
Reverses after liver transplantation
Abbreviations: FLAIR, fluid attenuation inversion recovery; HE, hepatic encephalopathy; MRS, magnetic resonance spectroscopy.
39. Latest Guidelines : In DIAGNOSIS
Hepatic encephalopathy should be treated as a continuum ranging from
unimpaired cognitive function with intact consciousness through coma
The diagnosis of HE is through exclusion of other causes of brain
dysfunction
Hepatic encephalopathy should be divided into various stages of
severity, reflecting the degree of selfsufficiency and the need for care
Overt hepatic encephalopathy is diagnosed by clinical criteria and can
be graded according the WHC and the GCS
40. The diagnosis and grading of MHE and CHE can be made
using several neurophysiological and psychometric tests that
should be performed by experienced examiners
Testing for MHE and CHE could be used in patients who
would most benefit from testing, such as those with impaired
quality of life or implication on employment or public safety
Increased blood ammonia alone does not add any diagnostic,
DE staging, or prognostic value for HE in patients with CLD.
A normal value calls for diagnostic reevaluation
41. TREATMENT : General principles
An episode of OHE (whether spontaneous or precipitated) should be
actively treated
Secondary prophylaxis after an episode for overt HE is recommended
Primary prophylaxis for prevention of episodes of OHE is not required,
except in patients with cirrhosis with a known high risk to develop HE .
Recurrent intractable OHE, together with liver failure, is an indication
for LiverTransplantation
42. SPECIFIC APPROACH TO OHE TREATMENT
A four-pronged approach to management of HE is recommended
1. Initiation of care for patients with altered consciousness: airway and ICU
management
2. Alternative causes of altered mental status should be sought and treated.
3. Identification of precipitating factors and their correction:
Controlling precipitating factors in the management of OHE is of paramount importance and
cornerstone treatment because nearly 90% of patients can be treated with just correction of
the precipitating factor
4. Commencement of empirical HE treatment
45. Treatment Of The Precipitating Factor
45
GI bleeding
Octreotide, IV PPI, endoscopic or angiographictherapy
Blood transfusions, correction of coagulopathy
NG lavage to remove blood from stomach
Infection Antibiotic therapy
Sedating medications Discontinue benzodiazepines, narcotics, consider flumazenil or naloxone
Electrolyte
abnormalities
Discontinue diuretics, perform serial paracentesis if needed
Correct hypokalemia or hyperkalemia, hyponatremia
Constipation Provide laxatives and enemas
Renal failure
Discontinue diuretics
Albumin administration
Discontinue nephrotoxic medications
47. Nonabsorbable Disaccharides : Lactulose
Theyare the 1st line therapy
Members: Lactulose and Lactilol [more palatable and less GIT upsets].
Action:
Laxative effect ammonia elimination.
Reduced NH3 synthesis and absorption:
Lactulose intestinal bacteria acetic and lactic acid pH [acidic media]
the synthesis and absorption of ammonia.
It increases movement of NH3 from blood to the GIT.
Lactulose colonic lactate and H ions NH3 NH4 non absorbable form.
Promote the growth of beneficial acid resistant, non–urease-
producing bacteria
48. Antibiotics
Neomycin:
It was the first antibiotic that was used.
It inhibits the intestinal glutaminase plus reduced ammonia
production by bacteria.
Dose: 3-4g/day.
Side effects: Ototoxicity, nephrotoxic [??].
Metronidazole:
Though effective but associated with resistance and peripheral
neuropathy.
Paromomycin and vancomycin
Is associated with bacterial resistance.
Vancomycin-resistant enterococcus 48
49. Rifaximin
Is minimally absorbed drug with very low systemic absorption and a high
barrier to resistance.
Recent meta-analysis: is equal or superior to lactulose with less abdominal
pain.
It is equal to neomycin but more NH3 lowering action with less side effects.
Rifaximin monotherapy is unproven so usually combined with lactulose.
Action:
Broad spectrum drug with low risk of resistance.
It acts against Gram-positive and Gram-negative organisms, both aerobes
and anaerobes.
Acts mainly in the small intestine with marked lowering bacterial effect.
Dose:
550mg /12hr.
AE:flatulence, abdominal pain, headaches, and constipation. 49
50. BCAAs
An updated meta-analysis of eight randomized, controlled trials (RCTs) indicated
that oral BCAA-enriched formulations improve the manifestations of episodic HE
whether OHE or MHE .
There is no effect of IV BCAA on the episodic bout of HE
L-ornithine L-aspartate (LOLA)
An RCT on patients with persistent HE demonstrated improvement by IV LOLA
in psychometric testing and postprandial venous ammonia levels.
Metabolic Ammonia Scavengers : Ornithine phenylacetate /Glyceryl
phenylbutyrate (GPB)
These agents, through their metabolism, act as urea surrogates excreted in urine
51. Glutaminase Inhibitors
Portosystemic shunting up-regulates the intestinal
glutaminase gene so that intestinal glutaminase inhibitors
may be useful by reducing the amounts of ammonia
produced by the gut.
52. Nutrition
Daily energy intakes should be 35-40 kcal/kg ideal body weight
Daily protein intake should be 1.2-1.5 g/kg/day
Small meals or liquid nutritional supplements evenly distributed
throughout the day and a late-night snack should be offered
Oral BCAA supplementation may allow recommended nitrogen
intake to be achieved and maintained in patients intolerant of dietary
protein
53. Liver Transplantation
53
Liver transplantation resolves both hepatic dysfunction and portal
hypertension
It usually results in complete resolution of HE.
Indication:
recurrent or treatment resistant cases.
MELD obstacle:
HE does not necessarily correlate with MELD score.
Patients with HE may be disadvantaged in the era of MELD-based organ
allocation despite a serious impact of HE on productivity, health, and
survival.